Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingKidney TransplantationHematopoietic Stem CellsHistocompatibilityCyclophosphamideTreatment OutcomeTransplantation, IsogeneicBone Marrow DiseasesRecurrenceTime FactorsCombined Modality TherapyHematopoiesisRetrospective StudiesImmunosuppressive AgentsRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteRemission InductionHematologic NeoplasmsAcetyl-CoA C-AcyltransferaseHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingAcute DiseaseBone Marrow NeoplasmsTransplantation ImmunologyFollow-Up StudiesGraft vs Host ReactionLeukemia, MyeloidSurvival AnalysisImmunosuppressionLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionCaproatesHeart TransplantationSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesSurvival RateProspective StudiesHLA AntigensMyelodysplastic SyndromesLung TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionNuclear FamilyPrognosisCarmustineOrgan TransplantationDisease-Free SurvivalPancytopeniaGraft vs Tumor EffectCell DifferentiationGraft vs Leukemia EffectCytarabineLeukocyte CountCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CEtoposideFlow CytometryLymphomaMultiple MyelomaPostoperative ComplicationsRisk FactorsCells, CulturedFatal OutcomeAntigens, CD34Hodgkin DiseaseMice, KnockoutInfection